The EPS miss vs consensus is likely to create near-term selling pressure, but the raised guidance and strong HSA asset growth underpin the long-term story. Watch for the conference call tone regarding HSA cash repricing dynamics and whether the massive buyback authorization provides a floor. The 90% analyst buy rating suggests consensus will focus on the non-GAAP beat and guidance raise.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 29 $87.99entry
- T+1 · 6mo ago +3.01%α +2.74% · $90.64
- T+5 · 6mo ago −3.16%α −2.87% · $85.21
- T+20 · 5mo ago −0.20%α +1.59% · $87.81
- T+60 · 3mo ago +19.79%α +18.60% · $105.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HealthEquity reported Q1 FY2027 revenue of $354.6M (+7% YoY), beating the $352.2M consensus, but GAAP EPS of $0.82 missed the $1.11 consensus estimate by 26%. The company raised fiscal 2027 guidance and authorized an additional $1.0B share repurchase, signaling confidence despite the headline EPS miss.
Key Financial Metrics
Key Facts
- Revenue of $354.6M beat consensus of $352.2M, up 7% YoY
- GAAP EPS of $0.82 missed consensus of $1.11 (non-GAAP EPS of $1.24 vs consensus N/A)
- Net income rose 29% to $69.4M, net income margin expanded to 20% from 16%
- Adjusted EBITDA grew 17% to $164.5M, margin expanded to 46% from 42%
- Total HSA assets grew 19% to $37.1B; HSAs with investments up 18%
- Board authorized $1.0B additional share repurchase; $123M spent in Q1
- Fiscal 2027 revenue guidance raised to $1.410-$1.420B; Adjusted EBITDA $625-$633M
Financial Impact
$354.6M revenue vs $352.2M consensus (+0.7% surprise); GAAP EPS $0.82 vs $1.11 consensus (-26.1% miss). Fiscal 2027 revenue guided to $1.410-$1.420B.
Risk Factors
- GAAP EPS miss of 26% vs consensus may weigh on the stock despite revenue beat
- HSA cash repricing schedule shows significant portion at low 1.8% yield through FY2027, limiting custodial revenue growth
- Rising expense base: total operating expenses grew 9% YoY, outpacing revenue growth
- Reliance on interest rate environment for custodial revenue; rate cuts could pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3303238 |
Track record
20 reports on HQY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $108.84 Now $104.58 −3.91% settles Dec 3
- Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $100.88 Now $104.58 +3.67% settles Nov 24
- Oct 19, 202628d ago Insider Cluster Neutral 2/10 Entry $96.60 Now $104.58 +8.26% settles Nov 17
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $92.03 to $102.11 Now $104.58 +13.64% ▲ +10.95% +14.22% vs SPY
- Oct 9, 20265w ago SC 13G/A Neutral 3/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers